The cellular geography of Aurora kinases

被引:0
|
作者
Mar Carmena
William C. Earnshaw
机构
[1] Wellcome Trust Centre for Cell Biology,
[2] Institute for Cell and Molecular Biology,undefined
[3] Kings Buildings,undefined
[4] University of Edinburgh,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Aurora family of conserved serine/threonine kinases perform essential functions during cell division. The three mammalian paralogues are very similar in sequence, but differ significantly in their localization, function, substrates and regulatory partners.Aurora A is mainly associated with the spindle poles during mitosis, where it is required for centrosome separation and maturation. Spindle assembly requires that targeting protein for XKLP 2 (TPX2) targets Aurora A to spindle pole microtubules through a mechanism that requires Ran–GTP. Aurora A also functions in meiosis, promoting oocyte maturation, polar-body extrusion, spindle positioning and exit from metaphase I.Regulation of Aurora A occurs through phosphorylation/dephosphorylation and degradation. Protein phosphatase 1 negatively regulates Aurora and this interaction is modulated by TPX2. The Cdh1/Fizzy-related form of anaphase-promoting complex/cyclosome (APC/C) targets Aurora for degradation in late mitosis.Aurora B is a chromosomal-passenger protein with multiple functions in mitosis. Inner centromere protein (INCENP) and survivin, two other components of the passenger complex, function as targeting and regulatory factors for the kinase. Aurora B is required for phosphorylation of histone 3, targeting of condensin and normal chromosome compaction. It has also been recently shown to be essential for chromosome biorentation, kinetochore–microtubule interactions and the spindle-assembly checkpoint.Aurora B is essential for completion of cytokinesis. Myosin II regulatory chain, vimentin, desmin and glial fibrillary acidic protein are among its cleavage furrow substrates. Aurora B phosphorylates MgcRacGAP transforming it into an activator of RhoA in the contractile ring.Much less is known about Aurora-C kinases, other than that they seem to be preferentially expressed in meiotic cells — they are not discussed here in detail.Misexpression of Aurora kinases is linked to cancer, but their possible role in carcinogenesis is yet to be elucidated.During the cell cycle, Aurora kinases travel to their subcellular targets aided by their binding partner-substrates, INCENP, survivin and TPX2. This provides an additional level of regulation that might be essential for the choreography of mitotic events.
引用
收藏
页码:842 / 854
页数:12
相关论文
共 50 条
  • [41] Aurora kinases as prognostic biomarkers in ovarian carcinoma
    Mendiola, Marta
    Barriuso, Jorge
    Marino-Enriquez, Adrian
    Redondo, Andres
    Dominguez-Caceres, Aurora
    Hernandez-Cortes, Gines
    Perez-Fernandez, Elia
    Sanchez-Navarro, Iker
    Fresno Vara, Juan Angel
    Suarez, Asuncion
    Espinosa, Enrique
    Gonzalez-Baron, Manuel
    Palacios, Jose
    Hardisson, David
    HUMAN PATHOLOGY, 2009, 40 (05) : 631 - 638
  • [42] AURORA KINASES: STRUCTURE, FUNCTIONS AND THEIR ASSOCIATION WITH CANCER
    Kollareddy, Madhu
    Dzubak, Petr
    Zheleva, Daniella
    Hajduch, Marian
    BIOMEDICAL PAPERS-OLOMOUC, 2008, 152 (01): : 27 - 33
  • [43] Characterisation of aurora-like kinases in plants
    Demidov, Dmitri
    Boernke, Frederik
    Houben, Andreas
    CHROMOSOME RESEARCH, 2007, 15 : 57 - 58
  • [44] Aurora kinases: shining lights on the therapeutic horizon?
    Andrews, PD
    ONCOGENE, 2005, 24 (32) : 5005 - 5015
  • [45] A new tool for identifying substrates of Aurora kinases
    Deretic, J.
    Kerr, A. R.
    Ly, T.
    Welburn, J. P.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [46] Progress in the development of selective inhibitors of Aurora kinases
    Mortlock, A
    Keen, NJ
    Jung, FH
    Heron, NM
    Foote, KM
    Wilkinson, R
    Green, S
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 199 - 213
  • [47] Aurora kinases dawn as cancer drug targets
    Sausville, EA
    NATURE MEDICINE, 2004, 10 (03) : 234 - 235
  • [48] Aurora kinases: shining lights on the therapeutic horizon?
    Paul D Andrews
    Oncogene, 2005, 24 : 5005 - 5015
  • [49] Molecular basis of drug resistance in Aurora kinases
    Girdler, Fiona
    Sessa, Fabio
    Patercoli, Simona
    Villa, Fabrizio
    Musacchio, Andrea
    Taylor, Stephen
    CHEMISTRY & BIOLOGY, 2008, 15 (06): : 552 - 562
  • [50] Investigating the role of Aurora Kinases in RAS signaling
    Kosik, Audrey
    Bekier, Michael E.
    Katusin, Jamie D.
    Kaur, Harpreet
    Zhou, Xiaofeng
    Diakonova, Maria
    Chadee, Deborah N.
    Taylor, William R.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 106 (01) : 33 - 41